Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00339599 · ClinicalTrials.gov registry record
Genetic Predictors of Cardiovascular Disease
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 2,306
- Enrollment target
NCT00339599: Completed study, sponsored by National Cancer Institute (NCI).
NCT00339599 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 2,306 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00339599 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 2,306 participants
- Enrollment target
Study Summary
This study, conducted in collaboration with the Johns Hopkins University School of Medicine, will explore the genetic influences on susceptibility to atherosclerotic cardiovascular disease (ASCVD). Atherosclerosis is a chronic narrowing of the arteries caused by an incremental buildup of fatty substances on the linings of walls of arteries. This study will examine the role of genes related to the inflammatory process on the incidence of ASCVD and on levels of chemokines (proteins involved in inflammation). DNA samples, chemokines levels and relevant clinical data from patients enrolled in Johns Hopkins's sibling and family heart studies are analyzed for specific gene markers. The studies include: Nurse Model in Black Families at Risk for Heart Disease; Genotypic Determinants of Aspirin Response in High Risk Families; and Coronary Disease Detection by Thallium SPECT and Fast CT. All of the enrolled patients have consented to have their DNA used for testing of genetic factors that may predict cardiovascular disease and do not contain patient identifier information.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,306 participants |
| Start Date | 2005-09-20 |
| Est. Completion | 2015-08-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00339599
The ClinicalTrials.gov registry entry for NCT00339599 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,306 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00339599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00339599 about?
NCT00339599 is a clinical study titled "Genetic Predictors of Cardiovascular Disease". This study, conducted in collaboration with the Johns Hopkins University School of Medicine, will explore the genetic influences on susceptibility to atherosclerotic cardiovascular disease (ASCVD). Atherosclerosis is a chronic narrowing of the arteries caused by an incremental buildup of fatty subst...
What is the current status of trial NCT00339599?
This trial is currently completed. The enrollment target is 2,306 participants. The study started on 2005-09-20. Estimated completion is 2015-08-03.
Who is sponsoring clinical trial NCT00339599?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.